Panacea Biotec receives order worth USD 24.32 mn for Pentavalent Vaccine
From UNICEF and PAHO
Panacea Biotec has received awards worth USD 24.32 million (over Rs 170 crore) from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP based Pentavalent Vaccine (DTwPHepB- Hib).UNICEF award is for calendar year 2020 and award of PAHO is for three (3) calendar years i.e. 2020-2022.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content